Pediatric Nephrology

, Volume 21, Issue 8, pp 1189–1193 | Cite as

Tuberous sclerosis complex and renal angiomyolipoma: case report and review of the literature

  • Elisabeth B. Winterkorn
  • Ghaleb H. Daouk
  • Sudha Anupindi
  • Elizabeth A. ThieleEmail author
Brief Report


A 5-year-old boy with a known diagnosis of tuberous sclerosis complex was found to have an enlarging renal mass on routine ultrasound. He was diagnosed with an angiomyolipoma (AML) and scheduled for close observation. Follow-up magnetic resonance imaging demonstrated the AML to be significantly enlarged and hypervascular. Selective arterial embolization of the tumor was performed, which resulted in an appropriate decrease in tumor size. Angiomyolipoma is a known and well-described complication of the tuberous sclerosis complex that is usually found among patients in their adolescent and adult years. The case presented here illustrates the need for early and repeated renal imaging of younger pediatric patients with tuberous sclerosis. Our experience adds to the literature on young pediatric patients requiring embolization for treatment of large renal angiomyolipomas.


Tuberous sclerosis complex Angiomyolipoma Selective arterial embolization 





end-stage renal disease


renal cell carcinoma


selective arterial embolization


tuberous sclerosis complex



This study was made possible by the support of the Carol and James Herscot Center for Tuberous Sclerosis Complex.


  1. 1.
    Curatolo P (2003) Tuberous sclerosis complex: from basic science to clinical phenotypes. Mack Keith Press, LondonGoogle Scholar
  2. 2.
    Bissada NK, Smith PL, White HJ, Barbour GL, Sun CN, Redman JF (1975) Tuberous Sclerosis complex and renal angiomyolipoma. Urology 6:105–113CrossRefGoogle Scholar
  3. 3.
    Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES (1988) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:140–145Google Scholar
  4. 4.
    Nelson CP, Sanda MG (2002) Contemporary diagnosis and management of renal angiomyolipoma. J Urol 168:1315–1325CrossRefGoogle Scholar
  5. 5.
    Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 6:792–796CrossRefGoogle Scholar
  6. 6.
    Bissler JJ, Kingswood JC (2004) Renal angiomyolipomata. Kidney Int 66:924–934CrossRefGoogle Scholar
  7. 7.
    Cook JA, Oliver K, Mueller RF, Sampson J (1996) A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet 33:480–484CrossRefGoogle Scholar
  8. 8.
    O’Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP (2004) An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 94:853–857CrossRefGoogle Scholar
  9. 9.
    Stillwell TJ, Gomez MR, Kelalis P (1987) Renal lesions in tuberous sclerosis. J Urol 138:477–481CrossRefGoogle Scholar
  10. 10.
    Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJM, Short MP, Dumars K, Roach ES, Steingold S, Wall S, Blanton SH, Flodman P, Kwiatkowski DJ, Jewell A, Weber JL, Roses AD, Pericak-Vance MA (1992) Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37–41CrossRefGoogle Scholar
  11. 11.
    Steiner MS, Goldman SM, Fishman EK, Marshall FF (1993) The natural history of renal angiomyolipoma. J Urol 150:1782–1786CrossRefGoogle Scholar
  12. 12.
    Lendvay TS, Marshall FF (2003) The tuberous sclerosis complex and its highly variable manifestations. J Urol 169:1635–1642CrossRefGoogle Scholar
  13. 13.
    Oesterling JE, Fishman EK, Goldman SM, Marshall FF (1986) The management of renal angiomyolipoma. J Urol 135:1121–1124CrossRefGoogle Scholar
  14. 14.
    Uhlenbrock D, Fischer C, Beyer HK (1988) Angiomyolipoma of the kidney: comparison between magnetic resonance imaging, computed tomography, and ultrasonography for diagnosis. Acta Radiol 29:523–526CrossRefGoogle Scholar
  15. 15.
    O’Hagan AR, Ellsworth R, Secic M, Rothner AD, Brouchard BH (1996) Renal manifestations of tuberous sclerosis complex. Clin Pediatr 35:483–489CrossRefGoogle Scholar
  16. 16.
    El-Hashemite N, Zhang H, Henske EP, Kwiatowski DJ (2003) Mutation in TSC2 and activation of mammalian target of rapamycin signaling pathway in renal angiomyolipoma. Lancet 361:1348–1349CrossRefGoogle Scholar
  17. 17.
    Niida Y, Stemmer-Rachamimov AO, Logrip M, Tapon D, Perez R, Kwiatkowski DJ, Sims K, MacCollin M, Louis DN, Ramesh V (2001) Somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet 69:493–503CrossRefGoogle Scholar
  18. 18.
    Tchaprassian A, Mognato G, Paradias G, D’Amore ESG, Tregnaghi A, Cecchetti G (1998) Renal angiomyolipoma in children: diagnostic difficulty in 3 patients. J Urol 159:1654–1656CrossRefGoogle Scholar
  19. 19.
    Kothary N, Soulen MC, Clark TWI, Wein AJ, Shlansky-Goldberg RD, Crino PB, Stavropoulos SW (2005) Renal angiomyolipoma: long term results after arterial embolization. J Vasc Interv Radiol 16:45–50CrossRefGoogle Scholar
  20. 20.
    Patel U, Simpson E, Kingswood JC, Saggar-Malik AK (2005) Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol 60:665–673CrossRefGoogle Scholar
  21. 21.
    Harabayashi T, Shinohara N, Katano H, Nonomura K, Shimizu T, Koyanagi T (2004) Management of renal angiomyolipomas associated with tuberous sclerosis complex. J Urol 171:102–105CrossRefGoogle Scholar
  22. 22.
    Bissler JJ, Racadio J, Donnelly LF, Johnson ND (2002) Reduction of postembolization syndrome after ablation of renal angiomyolipoma. Am J Kidney Dis 39:966–971CrossRefGoogle Scholar
  23. 23.
    Earthman WJ, Mazer MJ, Winfield AC (1986) Angiomyolipomas in tuberous sclerosis: subselective embolotherapy with alcohol, with long-term follow-up study. Radiology 160:437–441CrossRefGoogle Scholar
  24. 24.
    Kenerson H, Dundon TA, Yeung RS (2005) Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 57:67–75CrossRefGoogle Scholar
  25. 25.
    Kenerson HL, Aicher LD, True LD, Yeung RS (2002) Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 62:5645–5650PubMedGoogle Scholar
  26. 26.
    Casper KA, Donnelly LF, Chen B, Bissler JJ (2002) Tuberous sclerosis complex: renal imaging findings. Radiology 225:451–456CrossRefGoogle Scholar
  27. 27.
    Hyman MH, Whittemore VH (2000) National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 57:662–665CrossRefGoogle Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  • Elisabeth B. Winterkorn
    • 1
  • Ghaleb H. Daouk
    • 2
  • Sudha Anupindi
    • 3
  • Elizabeth A. Thiele
    • 1
    • 4
    Email author
  1. 1.Departments of Neurology and PediatricsMassachusetts General HospitalBostonUSA
  2. 2.Department of Pediatric NephrologyMassachusetts General HospitalBostonUSA
  3. 3.Department of Pediatric RadiologyMassachusetts General HospitalBostonUSA
  4. 4.The Herscot Center for Tuberous Sclerosis ComplexBostonUSA

Personalised recommendations